Patient Capital Management
Patient Capital Management reported 39 stocks worth $3B in its 13F filing for Q3 2026, filed Nov 12, 2026. Its largest holdings are RPRX (6.7%), C (6.0%) and GOOGL (6.0%). Compared with Q2 2026, the fund opened new positions in AVGO, IDRV and XHB, added to META, QXO and CHYM, trimmed RPRX, C and GOOGL and sold out of ILMN, PLAY and SPY.
Latest filing: what Patient Capital Management did in Q3 2026
vs Q2 2026Dollar changes use the share change at the quarter end price. New and sold out show the whole position.
Portfolio at a glance
share of reported value · Q3 2026Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 | ![]() RPRX Royalty Pharma PLC | $200M | 6.7% | 3.4M | −177K (−5%) | 8 of 8 | |
| 2 | ![]() C Citigroup Inc | $180M | 6.0% | 1.4M | −14K (−1%) | 8 of 8 | |
| 3 | ![]() GOOGL Alphabet Inc | $178M | 6.0% | 518K | −7,270 (−1%) | 8 of 8 | |
| 4 | ![]() AMZN Amazon Com Inc | $169M | 5.7% | 677K | −3,930 (−1%) | 8 of 8 | |
| 5 | ![]() NVDA Nvidia Corporation | $162M | 5.4% | 710K | No change | 8 of 8 | |
| 6 | ![]() UNH Unitedhealth Group Inc | $156M | 5.3% | 426K | −12K (−3%) | 6 of 8 | |
| 7 | ![]() PGEN Precigen Inc | $154M | 5.2% | 18M | −1.1M (−6%) | 8 of 8 | |
| 8 | ![]() META Meta Platforms Inc | $131M | 4.4% | 181K | +10K (+6%) | 8 of 8 | |
| 9 | ![]() QXO Qxo Inc | $128M | 4.3% | 10.9M | +3.8M (+53%) | 8 of 8 | |
| 10 | ![]() CHYM Chime Finl Inc | $126M | 4.2% | 4.7M | +648K (+16%) | 4 of 8 |
Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q2 2026, gone in Q3 2026Options
valued at the underlying sharesReported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q3 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Nov 12, 2026 | 13F-HR | Q3 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →Patient Capital Management 13F FAQ
What does Patient Capital Management own?
Patient Capital Management reported 39 stocks worth $3B in its 13F filing for Q3 2026, filed Nov 12, 2026. Its largest holdings are RPRX (6.7%), C (6.0%) and GOOGL (6.0%). The table above lists every position in the filing (the top 10 without an account).
What did Patient Capital Management buy and sell in Q3 2026?
Compared with Q2 2026: 3 new positions, 5 added to, 25 trimmed and 3 sold out. New positions include AVGO, IDRV and XHB. It sold all of ILMN, PLAY and SPY.
When will Patient Capital Management file its next 13F?
Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.
How much is Patient Capital Management's portfolio worth?
The Q3 2026 filing reports $3B in US stocks ($3.1B including options). That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.























